Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium.
The influence of serum on the production of retroviral vectors by the HT1080 human fibrosarcoma-derived packaging cell line FLYRD18 was investigated. A fourfold increase in virus titer was observed under serum-free conditions, as compared with medium supplemented with 10% fetal calf serum. A similar improvement was also seen for bulk transduction efficiency. Serum had a negative and dose-dependent effect on titer without affecting cell growth, virus stability, or infectivity. In contrast to virus from NIH 3T3-derived packaging cells [Hanenberg, H., et al. (1996). Nature Med. 2, 876-882], the FLYRD18-derived virus did not adhere to fibronectin or serum proteins adsorbed at the surface of culture flasks. Electron microscopy supports the conclusion that the effect of serum is at the level of virus production by the cells. Addition of soybean trypsin inhibitor had an inhibitory effect on virus production, while pretreatment of serum with trypsin was found to enhance the retroviral titer. These results suggest that protease inhibitors present in serum may be responsible for the inhibition of virus production. The exact mechanism remains, however, to be determined. As compared with medium supplemented with 10% serum, the combination of increased virus titer and absence of exogenous protein under serum-free conditions resulted in a 300-fold increase in the virus:total protein ratio in the supernatants harvested from the FLYRD18 packaging line. This improvement enhances prospects for further concentration and purification of the virus.
Gerin
P A
PA
School of Chemical Engineering, University of Birmingham, Edgbaston, England.
Gilligan
M G
MG
Searle
P F
PF
Al-Rubeai
M
M
D000818:Animals; D002417:Cattle; D002460:Cell Line / Q000821:virology; D003470:Culture Media; D016895:Culture Media, Serum-Free; D005822:Genetic Vectors / Q000235:genetics*; D006801:Humans; D009601:Nitroreductases / Q000235:genetics; D012190:Retroviridae / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D019076:Transgenes; D014779:Virus Replication
D003470:Culture Media; D016895:Culture Media, Serum-Free; D012710:Serum Albumin, Bovine; D009601:Nitroreductases